Zealand Pharma Pink Sheet Forward View
| ZLDPF Stock | USD 64.08 1.48 2.36% |
Zealand Pink Sheet outlook is based on your current time horizon. We suggest always using this module together with an analysis of Zealand Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 7th of February 2026 the relative strength index (rsi) of Zealand Pharma's share price is below 20 . This usually means that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Zealand Pharma hype-based prediction, you can estimate the value of Zealand Pharma AS from the perspective of Zealand Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Zealand Pharma AS on the next trading day is expected to be 63.95 with a mean absolute deviation of 1.88 and the sum of the absolute errors of 116.73. Zealand Pharma after-hype prediction price | USD 64.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Zealand |
Zealand Pharma Additional Predictive Modules
Most predictive techniques to examine Zealand price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Zealand using various technical indicators. When you analyze Zealand charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Zealand Pharma Naive Prediction Price Forecast For the 8th of February
Given 90 days horizon, the Naive Prediction forecasted value of Zealand Pharma AS on the next trading day is expected to be 63.95 with a mean absolute deviation of 1.88, mean absolute percentage error of 5.27, and the sum of the absolute errors of 116.73.Please note that although there have been many attempts to predict Zealand Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Zealand Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Zealand Pharma Pink Sheet Forecast Pattern
| Backtest Zealand Pharma | Zealand Pharma Price Prediction | Research Analysis |
Zealand Pharma Forecasted Value
In the context of forecasting Zealand Pharma's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Zealand Pharma's downside and upside margins for the forecasting period are 61.04 and 66.86, respectively. We have considered Zealand Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Zealand Pharma pink sheet data series using in forecasting. Note that when a statistical model is used to represent Zealand Pharma pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 121.6111 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.8828 |
| MAPE | Mean absolute percentage error | 0.0259 |
| SAE | Sum of the absolute errors | 116.7334 |
Predictive Modules for Zealand Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zealand Pharma AS. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Zealand Pharma After-Hype Price Density Analysis
As far as predicting the price of Zealand Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Zealand Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Zealand Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Zealand Pharma Estimiated After-Hype Price Volatility
In the context of predicting Zealand Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Zealand Pharma's historical news coverage. Zealand Pharma's after-hype downside and upside margins for the prediction period are 61.17 and 66.99, respectively. We have considered Zealand Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Zealand Pharma is very steady at this time. Analysis and calculation of next after-hype price of Zealand Pharma AS is based on 3 months time horizon.
Zealand Pharma Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Zealand Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zealand Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Zealand Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 2.91 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
64.08 | 64.08 | 0.00 |
|
Zealand Pharma Hype Timeline
Zealand Pharma AS is at this time traded for 64.08. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Zealand is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.08%. %. The volatility of related hype on Zealand Pharma is about 0.0%, with the expected price after the next announcement by competition of 64.08. About 56.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 3.26. Zealand Pharma AS had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be any time. Check out Historical Fundamental Analysis of Zealand Pharma to cross-verify your projections.Zealand Pharma Related Hype Analysis
Having access to credible news sources related to Zealand Pharma's direct competition is more important than ever and may enhance your ability to predict Zealand Pharma's future price movements. Getting to know how Zealand Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Zealand Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AKBLF | ALK Abell AS | 0.00 | 0 per month | 0.00 | 0.06 | 0.22 | 0.00 | 7.05 | |
| SHJBF | Shanghai Junshi Biosciences | 0.00 | 0 per month | 0.00 | (0.14) | 0.00 | 0.00 | 29.31 | |
| INCPF | InnoCare Pharma Limited | 0.00 | 0 per month | 0.00 | (0.25) | 0.00 | 0.00 | 7.79 | |
| HLUBF | H Lundbeck AS | 0.00 | 0 per month | 0.00 | (0.01) | 0.00 | 0.00 | 15.66 | |
| LABFF | Laboratorios Farmaceuticos Rovi | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GNNSF | Genscript Biotech | 0.00 | 0 per month | 0.00 | (0.07) | 0.00 | 0.00 | 32.18 | |
| HKMPY | Hikma Pharmaceuticals PLC | 0.00 | 0 per month | 0.00 | (0.11) | 2.79 | (3.23) | 13.68 | |
| HKMPF | Hikma Pharmaceuticals PLC | 0.00 | 0 per month | 0.00 | (0.14) | 2.10 | (2.48) | 11.56 | |
| HLBBF | H Lundbeck AS | 0.00 | 0 per month | 0.00 | (0.19) | 0.00 | (0.86) | 12.55 | |
| CAMRF | Camurus AB | 0.00 | 0 per month | 0.00 | 0 | 0.00 | (0.04) | 18.53 |
Other Forecasting Options for Zealand Pharma
For every potential investor in Zealand, whether a beginner or expert, Zealand Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Zealand Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Zealand. Basic forecasting techniques help filter out the noise by identifying Zealand Pharma's price trends.Zealand Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zealand Pharma pink sheet to make a market-neutral strategy. Peer analysis of Zealand Pharma could also be used in its relative valuation, which is a method of valuing Zealand Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Zealand Pharma Market Strength Events
Market strength indicators help investors to evaluate how Zealand Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zealand Pharma shares will generate the highest return on investment. By undertsting and applying Zealand Pharma pink sheet market strength indicators, traders can identify Zealand Pharma AS entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 64.08 | |||
| Day Typical Price | 64.08 | |||
| Price Action Indicator | 0.74 | |||
| Period Momentum Indicator | 1.48 |
Zealand Pharma Risk Indicators
The analysis of Zealand Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zealand Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zealand pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.87 | |||
| Standard Deviation | 3.17 | |||
| Variance | 10.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Zealand Pharma
The number of cover stories for Zealand Pharma depends on current market conditions and Zealand Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Zealand Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Zealand Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Zealand Pink Sheet
Zealand Pharma financial ratios help investors to determine whether Zealand Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zealand with respect to the benefits of owning Zealand Pharma security.